Actively Recruiting
Impact of Sodium Bicarbonate on 24-hour Urine Parameters in Hypocitriuric and Uric Acid Stone Formers
Led by University of California, Irvine · Updated on 2025-06-24
100
Participants Needed
1
Research Sites
60 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The incidence of kidney stone disease continues to rise globally. Although the treatment of kidney stone disease has dramatically improved in recent years, surgical management remains invasive and expensive. Patients who develop kidney stones are at high risk of recurrence during their lifetime; therefore, prevention of stones should be a primary focus. Low levels of citrate and acidic urine are risk factors for the formation of kidney stones such as calcium oxalate and uric acid, respectively. Calcium oxalate stones are the predominant stone composition in the United States, accounting for over 2/3rds of stones. Citrate is a key inhibitor of calcium oxalate crystal formation and thus increasing it in the urine of a calcium oxalate stone former is quite beneficial. Uric acid stones account for approximately 10 percent of all stone types. These stones form primarily due to an acidic urinary environment which is a prerequisite for crystal formation. Common medications for stone formers include potassium citrate which help to make the urine more alkaline. Although effective, these medications have side effects and may prove to be too expensive (upwards of $450/month). Consuming baking soda (sodium bicarbonate) may prove to be an inexpensive ($0.34/month) equally effective alternative with respect to increasing urinary citrate levels and alkalinizing the urine. Investigators hypothesize that twice a day oral baking soda in a liquid medium (e.g., water, orange juice, soda, etc.) can be an effective, and inexpensive alternative to urocit K with regard to alkalinizing the urine and raising urinary citrate levels.
CONDITIONS
Official Title
Impact of Sodium Bicarbonate on 24-hour Urine Parameters in Hypocitriuric and Uric Acid Stone Formers
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age greater than 18 years and less than 80 years
- Hypocitriuric (less than 320 mg/24 hours) calcium oxalate or uric acid stone formers
- Currently on Urocit-K (potassium citrate) therapy as standard care
You will not qualify if you...
- Younger than 18 years or older than 80 years
- Currently taking thiazide or ACE inhibitor medications
- Pregnant women
- Women who are breastfeeding or plan to breastfeed during the study
- History of abnormal kidney function (eGFR less than 60 mL/min/1.73 m2)
- Active urinary tract infection
- Diabetes
- Cystinuria
- Renal tubular acidosis
- Inflammatory bowel disease
- Chronic diarrhea
- Primary hyperparathyroidism
- Peptic ulcer disease
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of California, Irvine Medical Center
Orange, California, United States, 92868
Actively Recruiting
Research Team
S
Sohrab N Ali, M.D
CONTACT
R
Renai Yoon, B.S.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here